Mettler-Toledo International Inc. (MTD): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Mettler-Toledo International ( MTD) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 2.0%. By the end of trading, Mettler-Toledo International fell $2.63 (-1.1%) to $247.01 on average volume. Throughout the day, 243,534 shares of Mettler-Toledo International exchanged hands as compared to its average daily volume of 193,600 shares. The stock ranged in price between $246.70-$250.37 after having opened the day at $249.49 as compared to the previous trading day's close of $249.64. Other companies within the Health Care sector that declined today were: IntelliPharmaCeutics International ( IPCI), down 9.7%, Escalon Medical Corporation ( ESMC), down 7.5%, iBio ( IBIO), down 6.0% and CAS Medical Systems ( CASM), down 5.5%.

(dormant client) Postfach Mt-100 CH-8606 Greifensee, Switzerland 011-411-944-3634. Mettler-Toledo International has a market cap of $7.3 billion and is part of the electronics industry. Shares are up 2.9% year to date as of the close of trading on Friday. Currently there are 4 analysts that rate Mettler-Toledo International a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Mettler-Toledo International as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, Aoxing Pharmaceutical Company ( AXN), up 55.9%, Prana Biotechnology ( PRAN), up 39.3%, Forest Laboratories ( FRX), up 27.5% and Skystar Bio-Pharmaceutical Company ( SKBI), up 13.4% , were all gainers within the health care sector with Celgene Corporation ( CELG) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Three Big Factors That Rocked the Stock Market Tuesday

Three Big Factors That Rocked the Stock Market Tuesday

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles Over 400 Points; S&P 500 and Nasdaq Also Finish Lower

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug